J.L. Bainbridge & Co’s CVS Health CVS Stock Holding History

J.L. Bainbridge & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,891	Closed	-$268K	–	72
2022 Q2	$268K	Sell	2,891 -468,616	-99%	-$45.7M	0.04%	57
2022 Q1	$47.7M	Sell	471,507 -4,277	-0.9%	-$449K	5.44%	4
2021 Q4	$49.1M	Sell	475,784 -2,079	-0.4%	-$192K	5.46%	4
2021 Q3	$40.6M	Sell	477,863 -2,749	-0.6%	-$230K	4.84%	4
2021 Q2	$40.1M	Sell	480,612 -373	-0.1%	-$30.5K	4.79%	5
2021 Q1	$36.2M	Buy	480,985 +5,073	+1%	+$370K	4.77%	7
2020 Q4	$32.5M	Buy	475,912 +4,068	+0.9%	+$265K	4.58%	7
2020 Q3	$27.6M	Buy	471,844 +13,258	+3%	+$825K	4.37%	7
2020 Q2	$29.8M	Buy	458,586 +5,785	+1%	+$364K	5.42%	6
2020 Q1	$26.9M	Buy	452,801 +871	+0.2%	+$58.1K	5.11%	8
2019 Q4	$33.6M	Buy	+451,930	New	+$31.7M	4.67%	9

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J.L. Bainbridge & Co's CVS Position: Q3 2022 in Review

J.L. Bainbridge & Co sold out of CVS Health (CVS) in Q3 2022, closing a stake of 2,891 shares — an estimated $268K sold.

J.L. Bainbridge & Co first reported a position in CVS in Q4 2019 and held it in 11 quarters. The position peaked at $49.1M in Q4 2021. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

J.L. Bainbridge & Co reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
J.L. Bainbridge & Co sold 2,891 CVS Health shares in Q3 2022, an estimated $268K.
J.L. Bainbridge & Co first reported a position in CVS Health in Q4 2019 and held it in 11 quarters.
J.L. Bainbridge & Co's CVS Health position peaked at $49.1M in Q4 2021.
2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on J.L. Bainbridge & Co's 13F filing for Q3 2022, filed 2 Nov 2022.